Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Catecholamines, such as epinephrine, norepinephrine, and dopamine, are endogenous compounds that play a critical role in the regulation of heart rate and contractility. Their use in the treatment of arrhythmias is scientifically validated, but the context is specific. Catecholamines are primarily used in emergency settings, such as cardiac arrest or severe bradyarrhythmias, where they act as sympathomimetic agents to stimulate beta-adrenergic receptors in the heart. This stimulation increases heart rate (positive chronotropy) and the force of cardiac contraction (positive inotropy), which can help restore effective cardiac rhythm in cases of asystole or profound bradycardia.

However, catecholamines are not used to treat all arrhythmias—rather, their role is limited to specific life-threatening conditions such as cardiac arrest (e.g., epinephrine is a standard therapy in advanced cardiac life support, ACLS) and symptomatic bradycardia unresponsive to other interventions. On the other hand, in tachyarrhythmias, catecholamines are generally contraindicated as they can worsen the arrhythmia. The evidence base for their use in resuscitation and severe bradycardia is moderate and primarily based on large clinical guidelines (such as those from the American Heart Association) and observational data, rather than randomized controlled trials. Therefore, while their use in certain arrhythmias is well-established in practice and supported by scientific guidelines, the overall evidence rating is moderate (3/5), reflecting the specificity and limitations of their use.

More about Catecholamine
More about Arrhythmia

Other ingredients used for Arrhythmia

Other health conditions supported by Catecholamine

Products containing Catecholamine